A review of current induction strategies and emerging prognostic factors in the management of children and adolescents with acute lymphoblastic leukemia
Saveria Capria(Sapienza University of Rome), Anna Maria Testi(Sapienza University of Rome), Sabina Chiaretti(Sapienza University of Rome), Maria Luisa Moleti(Sapienza University of Rome), Sara Mohamed(Royal College of Surgeons in Ireland - Bahrain), Matteo Molica(Sapienza University of Rome), Silvia Maria Trisolini(Radboud University Nijmegen), Simona Bianchi(Sapienza University of Rome)
Cited by 15
Related Papers
Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity
|Cytokine|2015|505
High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial
|Journal of Clinical Oncology|2013|168
Chlorambucil plus rituximab with or without maintenance rituximab as first‐line treatment for elderly chronic lymphocytic leukemia patients
|American Journal of Hematology|2014|114